Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline-hydroxyethylstarch versus isotonic saline in male coronary bypass surgery patients
2010-019352-42Phase 4Completed
- Sponsor
- Tampere Heart Hospital
- Start
- Jun 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of HyperHAES and sodium chloride in coronary arteriosclerosis (2 arms), sponsored by Tampere Heart Hospital. Primary endpoints: Change in body weight and Change in extracellular water. Started Jun 2010; status: completed.
02
Drugs
HyperHAESsodium chloride
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2010-019352-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019352-42.